The University of Southampton
University of Southampton Institutional Repository

Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis

Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis
Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis

Current methods for tuberculosis treatment monitoring are suboptimal. We evaluated plasma matrix metalloproteinase (MMP) and procollagen III N-terminal propeptide concentrations before and during tuberculosis treatment as biomarkers. Plasma MMP-1, MMP-8, and MMP-10 concentrations significantly decreased during treatment. Plasma MMP-8 was increased in sputum Mycobacterium tuberculosis culture-positive relative to culture-negative participants, before (median, 4993 pg/mL [interquartile range, 2542-9188] vs 698 [218-4060] pg/mL, respectively; P = .004) and after (3650 [1214-3888] vs 720 [551-1321] pg/mL; P = .008) 6 months of tuberculosis treatment. Consequently, plasma MMP-8 is a potential biomarker to enhance tuberculosis treatment monitoring and screen for possible culture positivity.

HIV, Tuberculosis, diagnosis, immunopathology, matrix metalloproteinase, procollagen III N-terminal propeptide
0022-1899
928-932
Walker, NF
e586ffdf-ae4b-46fa-83a1-db72501d17c1
Karim, F
5f47c4e2-5e49-4c6d-84bd-ba1f844ff8db
Moosa, MY
592c5c37-7cbf-492b-8b08-09c98ccc6722
Moodley, S
e566a64b-63da-450f-abe1-138126f0db37
Mazibuko, M
6cc55990-5635-4f2e-93bd-1d1eae8f8d9a
Khan, K
5192320a-e791-4cfe-b4b9-2e604e5617ec
Sterling, TR
6e418c68-68f6-48d2-a3c4-6663d25fc906
van der Heijden, YF
fd88a1dd-178e-4f84-a2f2-18395829a52f
Grant, AD
bfd4d62c-1239-4d1b-aad6-83445ff7c950
Elkington, Paul
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Pym, A
0715fc48-af68-477b-9c1f-ed6b51d4bf5f
Leslie, A
9521da48-518e-40c1-890c-0cd8e20f9494
Walker, NF
e586ffdf-ae4b-46fa-83a1-db72501d17c1
Karim, F
5f47c4e2-5e49-4c6d-84bd-ba1f844ff8db
Moosa, MY
592c5c37-7cbf-492b-8b08-09c98ccc6722
Moodley, S
e566a64b-63da-450f-abe1-138126f0db37
Mazibuko, M
6cc55990-5635-4f2e-93bd-1d1eae8f8d9a
Khan, K
5192320a-e791-4cfe-b4b9-2e604e5617ec
Sterling, TR
6e418c68-68f6-48d2-a3c4-6663d25fc906
van der Heijden, YF
fd88a1dd-178e-4f84-a2f2-18395829a52f
Grant, AD
bfd4d62c-1239-4d1b-aad6-83445ff7c950
Elkington, Paul
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Pym, A
0715fc48-af68-477b-9c1f-ed6b51d4bf5f
Leslie, A
9521da48-518e-40c1-890c-0cd8e20f9494

Walker, NF, Karim, F, Moosa, MY, Moodley, S, Mazibuko, M, Khan, K, Sterling, TR, van der Heijden, YF, Grant, AD, Elkington, Paul, Pym, A and Leslie, A (2022) Elevated plasma matrix metalloproteinase-8 associates with sputum culture positivity in pulmonary tuberculosis. The Journal of Infectious Diseases, 226 (5), 928-932, [jiac160]. (doi:10.1093/infdis/jiac160).

Record type: Article

Abstract

Current methods for tuberculosis treatment monitoring are suboptimal. We evaluated plasma matrix metalloproteinase (MMP) and procollagen III N-terminal propeptide concentrations before and during tuberculosis treatment as biomarkers. Plasma MMP-1, MMP-8, and MMP-10 concentrations significantly decreased during treatment. Plasma MMP-8 was increased in sputum Mycobacterium tuberculosis culture-positive relative to culture-negative participants, before (median, 4993 pg/mL [interquartile range, 2542-9188] vs 698 [218-4060] pg/mL, respectively; P = .004) and after (3650 [1214-3888] vs 720 [551-1321] pg/mL; P = .008) 6 months of tuberculosis treatment. Consequently, plasma MMP-8 is a potential biomarker to enhance tuberculosis treatment monitoring and screen for possible culture positivity.

Text
CUBS_MMP_v1.4_accepted
Download (1MB)
Text
jiac160
Download (1MB)

More information

Accepted/In Press date: 25 April 2022
Published date: 13 September 2022
Additional Information: © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Keywords: HIV, Tuberculosis, diagnosis, immunopathology, matrix metalloproteinase, procollagen III N-terminal propeptide

Identifiers

Local EPrints ID: 456987
URI: http://eprints.soton.ac.uk/id/eprint/456987
ISSN: 0022-1899
PURE UUID: 7789dad9-056a-46a2-99c4-1ae3349e6847
ORCID for Paul Elkington: ORCID iD orcid.org/0000-0003-0390-0613

Catalogue record

Date deposited: 19 May 2022 16:31
Last modified: 17 Mar 2024 07:16

Export record

Altmetrics

Contributors

Author: NF Walker
Author: F Karim
Author: MY Moosa
Author: S Moodley
Author: M Mazibuko
Author: K Khan
Author: TR Sterling
Author: YF van der Heijden
Author: AD Grant
Author: Paul Elkington ORCID iD
Author: A Pym
Author: A Leslie

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×